Table 2 Prescription pattern for antimalarial drug combination and monotherapy
Antimalarial drug regimens prescribed | Frequency of prescription (% n) | |
|---|---|---|
| Â | Government hospitals (n = 348) | Private Clinics (n = 317) |
Monotherapy | 263(75.6) | 264 (83.3) |
Chloroquine | 82 (23.6) | 119 (37.5) |
Sulphadoxine-pyrimethamine (SP) | 92 (26.4) | 59 (18.6) |
Artemisinin | 59 (16.9) | 46 (14.5) |
Quinine | 16 (4.6) | 28 (8.8) |
Halofantrine | 2 (0.6) | 6 (1.9) |
Amodiaquine | 3 (0.9) | 0 (0.0) |
Combination therapy | 85 (24.4) | 53 (16.7) |
Chloroquine-SP | 35 (10.1) | 16 (5.0) |
Quinine-SP | 32 (9.2) | 24 (7.6) |
Mefloquine-SP | 0 (0.0) | 11 (3.5) |
Artemisinin-SP | 2 (0.6) | 2 (0.6) |
Artemether+lumefantrine | 16 (4.6) | 0 (0.0) |
Insufficient data to determine | 9 (2.6) | 6 (1.9) |